Table 2 Modified minimum inhibitory concentration of vancomycin, meropenem, and ciprofloxacin upon administration with sCur (8 µg/ml) against MDR pathogens.

From: Making of water soluble curcumin to potentiate conventional antimicrobials by inducing apoptosis-like phenomena among drug-resistant bacteria

Isolates

Vancomycin modified MIC (µg/ml)

Meropenem modified MIC (µg/ml)

Ciprofloxacin modified MIC (µg/ml)

Staphylococcus aureus (MRSA, 2,862/2019)

0.25

–

1

Klebsiella pneumoniae (10,825/2019)

16

2

2

Escherichia coli (507/2019)

8

1

1

Pseudomonas aeruginosa (2,412/2019)

16

4

2

Back to article page